These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5857629)

  • 1. [Our experience in the treatment of terminal cases].
    Vakhovskiĭ AI
    Klin Khir (1962); 1965 Apr; 5():41-5. PubMed ID: 5857629
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics.
    Weber C; Zulian GB
    Am J Hosp Palliat Care; 2009; 26(2):84-8. PubMed ID: 19088264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Care of the dying.
    Bennett MB
    S Afr Med J; 1973 Sep; 47(34):1558-60. PubMed ID: 4126272
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical efficacy of octreotide acetate in cancer patients with malignant bowel symptoms depend on terminal stage].
    Uchino R; Kusano S; Hanada N; Ohara C; Okino T; Yamaguchi K
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):255-7. PubMed ID: 21368489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of octreotide in bowel obstruction.
    Mercadante S
    Palliat Med; 1993; 7(1):78. PubMed ID: 8287204
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of malignant intestinal obstruction. A prospective study over 80 cases].
    Arvieux C; Laval G; Mestrallet JP; Stefani L; Villard ML; Cardin N
    Ann Chir; 2005 Sep; 130(8):470-6. PubMed ID: 16084483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide acetate administration for malignant bowel obstruction induces severe bradycardia in patients with terminal stage cancer: two case reports.
    Kubota K; Hasumi Y; Numata A; Tukazaki T; Horie K; Hashimoto K; Yokota H
    J Palliat Med; 2013 Jun; 16(6):596-7. PubMed ID: 23600413
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?
    Laval G; Girardier J; Lassaunière JM; Leduc B; Haond C; Schaerer R
    Palliat Med; 2000 Jan; 14(1):3-10. PubMed ID: 10717717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of malignant bowel obstruction.
    Gamlin's R
    Int J Palliat Nurs; 2001 Nov; 7(11):565. PubMed ID: 11775932
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of sudden death caused by intestinal obstruction].
    Hitosugi M; Kitamura O; Shigeta A; Takatsu A; Yoshino Y; Ohtsuki M
    Nihon Hoigaku Zasshi; 1997 Dec; 51(6):423-9. PubMed ID: 9545755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive pharmacological treatment for reversing malignant bowel obstruction.
    Mercadante S; Ferrera P; Villari P; Marrazzo A
    J Pain Symptom Manage; 2004 Oct; 28(4):412-6. PubMed ID: 15471659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of granisetron in the antiemetic control of nonsurgical intestinal obstruction in advanced cancer: a phase II clinical trial.
    Tuca A; Roca R; Sala C; Porta J; Serrano G; González-Barboteo J; Gómez-Batiste X
    J Pain Symptom Manage; 2009 Feb; 37(2):259-70. PubMed ID: 18789638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient management of small bowel obstruction in terminal ovarian cancer.
    Hopkins MP; Roberts JA; Morley GW
    J Reprod Med; 1987 Nov; 32(11):827-9. PubMed ID: 3123672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant bowel obstruction: individualized treatment near the end of life.
    Soriano A; Davis MP
    Cleve Clin J Med; 2011 Mar; 78(3):197-206. PubMed ID: 21364165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intestinal obstruction in colorectal neoplasms. Our experience with 50 cases].
    Borgna E; Caponi R; Giordanello V; Scanavino A; Della Valle E
    Minerva Chir; 1992 May; 47(10):925-8. PubMed ID: 1630685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant bowel obstruction: so much more than symptom control.
    Platt V
    Int J Palliat Nurs; 2001 Nov; 7(11):547-54. PubMed ID: 11775930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effective made of octreotide intravenous administration for malignant gastrointestinal obstruction in terminal cancer patients].
    Tanimura K; Onda S; Mitsunobu M
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1991-3. PubMed ID: 20948271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for TPN in terminally ill patients with bowel obstruction?
    Duerksen DR; Ting E; Thomson P; McCurdy K; Linscer J; Larsen-Celhar S; Brennenstuhl E
    Nutrition; 2004 Sep; 20(9):760-3. PubMed ID: 15325683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care of the dying. Symptom control.
    Twycross RG
    Br J Hosp Med; 1986 Oct; 36(4):244-6, 248-9. PubMed ID: 3768616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nausea is a common symptom in palliative care. Choice of treatment is based on the cause].
    Strang P; Jakobsson M
    Lakartidningen; 1999 Apr; 96(14):1743-5. PubMed ID: 10222693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.